Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Prana – ANA Abstract Submission NLP

October 17, 2016 Kerry Rowe

final-ana-abstract-submission-nlp-4-8-16

Post navigation

New data from Reach2HD trial presented at American Neurological Association Annual Meeting

Related Posts

IMAGINE Phase 2 clinical trial Investor Conference call

March 1, 2014

Prana Announces A$6.0 Million Capital Raising

July 17, 2013

Prana meeting with investors at world’s largest healthcare conference in San Francisco

January 8, 2018

Recent Posts

Alterity to present at the 7th International Congress of Multiple System Atrophy
Alterity Half Year Results and Investor Webcast Notification
Alterity announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson’s disease clinical trials
Quarterly Cash Flow Report
New hope in global fight against antibiotic resistant superbugs

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065